363 related articles for article (PubMed ID: 26507858)
1. The Swedish Crohn Trial: A Prematurely Terminated Randomized Controlled Trial of Thiopurines or Open Surgery for Primary Treatment of Ileocaecal Crohn's Disease.
Gerdin L; Eriksson AS; Olaison G; Sjödahl R; Ström M; Söderholm JD; Myrelid P
J Crohns Colitis; 2016 Jan; 10(1):50-4. PubMed ID: 26507858
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
Ponsioen CY; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Bossuyt PMM; Hart A; Warusavitarne J; Buskens CJ; van Bodegraven AA; Brink MA; Consten ECJ; van Wagensveld BA; Rijk MCM; Crolla RMPH; Noomen CG; Houdijk APJ; Mallant RC; Boom M; Marsman WA; Stockmann HB; Mol B; de Groof AJ; Stokkers PC; D'Haens GR; Bemelman WA;
Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):785-792. PubMed ID: 28838644
[TBL] [Abstract][Full Text] [Related]
3. Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres.
de Buck van Overstraeten A; Eshuis EJ; Vermeire S; Van Assche G; Ferrante M; D'Haens GR; Ponsioen CY; Belmans A; Buskens CJ; Wolthuis AM; Bemelman WA; D'Hoore A
Br J Surg; 2017 Nov; 104(12):1713-1722. PubMed ID: 28745410
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease.
Aaltonen G; Keränen I; Carpelan-Holmström M; Lepistö A
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1143-1147. PubMed ID: 30024490
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO
J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661
[TBL] [Abstract][Full Text] [Related]
6. Complications after end-to-end vs. side-to-side anastomosis in ileocecal Crohn's disease--early postoperative results from a randomized controlled multi-center trial (ISRCTN-45665492).
Zurbuchen U; Kroesen AJ; Knebel P; Betzler MH; Becker H; Bruch HP; Senninger N; Post S; Buhr HJ; Ritz JP;
Langenbecks Arch Surg; 2013 Mar; 398(3):467-74. PubMed ID: 22290216
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial.
Stocchi L; Milsom JW; Fazio VW
Surgery; 2008 Oct; 144(4):622-7; discussion 627-8. PubMed ID: 18847647
[TBL] [Abstract][Full Text] [Related]
8. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group.
Ewe K; Böttger T; Buhr HJ; Ecker KW; Otto HF
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):277-82. PubMed ID: 10333200
[TBL] [Abstract][Full Text] [Related]
9. Effect of intestinal resection on quality of life in Crohn's disease.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow MP; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
J Crohns Colitis; 2015 Jun; 9(6):452-62. PubMed ID: 25855073
[TBL] [Abstract][Full Text] [Related]
10. Modified Side-To-Side Isoperistaltic Strictureplasty over the Ileocaecal Valve: An Alternative to Ileocaecal Resection in Extensive Terminal Ileal Crohn's Disease.
de Buck van Overstraeten A; Vermeire S; Vanbeckevoort D; Rimola J; Ferrante M; Van Assche G; Wolthuis A; D'Hoore A
J Crohns Colitis; 2016 Apr; 10(4):437-42. PubMed ID: 26674959
[TBL] [Abstract][Full Text] [Related]
11. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
[TBL] [Abstract][Full Text] [Related]
12. Myenteric plexitis at the proximal resection margin is a predictive marker for surgical recurrence of ileocaecal Crohn's disease.
Misteli H; Koh CE; Wang LM; Mortensen NJ; George B; Guy R
Colorectal Dis; 2015 Apr; 17(4):304-10. PubMed ID: 25581299
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
Stevens TW; Haasnoot ML; D'Haens GR; Buskens CJ; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Mol B; Stokkers PCF; Bemelman WA; Ponsioen CY;
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):900-907. PubMed ID: 32619413
[TBL] [Abstract][Full Text] [Related]
14. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
15. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial.
de Groof EJ; Stevens TW; Eshuis EJ; Gardenbroek TJ; Bosmans JE; van Dongen JM; Mol B; Buskens CJ; Stokkers PCF; Hart A; D'Haens GR; Bemelman WA; Ponsioen CY;
Gut; 2019 Oct; 68(10):1774-1780. PubMed ID: 31233395
[TBL] [Abstract][Full Text] [Related]
17. Assessment of long-term quality of life after laparoscopic and open surgery for Crohn's disease.
Thaler K; Dinnewitzer A; Oberwalder M; Weiss EG; Nogueras JJ; Wexner SD
Colorectal Dis; 2005 Jul; 7(4):375-81. PubMed ID: 15932562
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic-assisted versus conventional ileocolectomy for primary Crohn's disease: results of a comparative study.
Makni A; Chebbi F; Ksantini R; Fétirich F; Bedioui H; Jouini M; Kacem M; Ben Mami N; Filali A; Ben Safta Z
J Visc Surg; 2013 Apr; 150(2):137-43. PubMed ID: 23092647
[TBL] [Abstract][Full Text] [Related]
20. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
